医学研究与教育 ›› 2014, Vol. 31 ›› Issue (4): 88-90,99.DOI: 10.3969/j.issn.1674-490X.2014.04.020

• 综述 • 上一篇    下一篇

对比剂急性肾损伤的早期生物学标志物的研究进展

王娴君1,吴尚勤2   

  1. 1.天津市第四中心医院,天津,300140
    2.天津市胸科医院,天津,300382
  • 收稿日期:2016-09-29 修回日期:2016-09-29 出版日期:2014-08-25 发布日期:2014-08-25

Advances on early renal damage biomarkers of contrast-induced acute kidney injury

WANG Xianjun1,WU Shangqin2   

  • Received:2016-09-29 Revised:2016-09-29 Online:2014-08-25 Published:2014-08-25

摘要: 对比剂急性肾损伤是介入诊疗术严重的并发症之一。通过监测一些指标的变化可以早期发现对比剂所致的急性肾损伤,这对于对比剂急性肾损害的早期诊断和早期治疗、延缓病情发展有极其重要意义。现就近几年监测对比剂急性肾损伤的早期生物学标志物的研究情况做以综述。

关键词: 对比剂肾病, 急性肾损伤, 标志物, 进展

Abstract: Contrast-induced acute kidney injury(CI-AKI) is one complication of coronary intervention due to the use of contrast medium. Early renal damage caused by contrast medium can be detected through monitoring specific markers. It is important to detect the early renal damage for efficient clinical assessment to provide therapy for contrast-induced nephropathy thus delaying the progression of disease. This article gives an overview of the biomarkers used to detect early renal damage in contrast-induced acute kidney injury.

Key words: contrast-induced nephropathy, early renal damage, biomarkers, advances

中图分类号: